165 related articles for article (PubMed ID: 25633211)
41. Noncoding RNAs in Critical Limb Ischemia.
Pérez-Cremades D; Cheng HS; Feinberg MW
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):523-533. PubMed ID: 31893949
[TBL] [Abstract][Full Text] [Related]
42. Beperminogene perplasmid for the treatment of critical limb ischemia.
Suda H; Murakami A; Kaga T; Tomioka H; Morishita R
Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1145-56. PubMed ID: 25190335
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial.
Powell RJ; Dormandy J; Simons M; Morishita R; Annex BH
Vasc Med; 2004 May; 9(3):193-8. PubMed ID: 15675184
[TBL] [Abstract][Full Text] [Related]
44. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
[TBL] [Abstract][Full Text] [Related]
45. Gram-scale production of plasmid pUDK-HGF with current good manufacturing practices for gene therapy of critical limb ischemia.
Hu C; Cheng X; Lu Y; Wu Z; Zhang Q
Prep Biochem Biotechnol; 2016 Nov; 46(8):844-849. PubMed ID: 26853514
[TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia.
Palmer-Kazen U; Wariaro D; Luo F; Wahlberg E
J Vasc Surg; 2004 Mar; 39(3):621-8. PubMed ID: 14981457
[TBL] [Abstract][Full Text] [Related]
47. Plasmid DNA-based gene transfer with ultrasound and microbubbles.
Taniyama Y; Azuma J; Rakugi H; Morishita R
Curr Gene Ther; 2011 Dec; 11(6):485-90. PubMed ID: 22023478
[TBL] [Abstract][Full Text] [Related]
48. Gene therapy for ischemic heart disease.
Lavu M; Gundewar S; Lefer DJ
J Mol Cell Cardiol; 2011 May; 50(5):742-50. PubMed ID: 20600100
[TBL] [Abstract][Full Text] [Related]
49. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
Okamoto N; Tanaka A; Jung K; Karasawa K; Orito K; Matsuda A; Amagai Y; Oida K; Ohmori K; Matsuda H
Cardiovasc Res; 2011 Nov; 92(2):209-17. PubMed ID: 21771896
[TBL] [Abstract][Full Text] [Related]
50. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases].
Aoki M; Ogihara T; Morishita R
Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086
[TBL] [Abstract][Full Text] [Related]
51. Stem cell-based peripheral vascular regeneration.
Fujita Y; Kawamoto A
Adv Drug Deliv Rev; 2017 Oct; 120():25-40. PubMed ID: 28912015
[TBL] [Abstract][Full Text] [Related]
52. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
53. Riferminogene pecaplasmide.
Am J Cardiovasc Drugs; 2010; 10(5):343-6. PubMed ID: 20860417
[TBL] [Abstract][Full Text] [Related]
54. Plasmid-mediated gene therapy for cardiovascular disease.
Williams PD; Kingston PA
Cardiovasc Res; 2011 Sep; 91(4):565-76. PubMed ID: 21742674
[TBL] [Abstract][Full Text] [Related]
55. Progress of Gene Therapy in Cardiovascular Disease.
Shimamura M; Nakagami H; Sanada F; Morishita R
Hypertension; 2020 Oct; 76(4):1038-1044. PubMed ID: 32772646
[TBL] [Abstract][Full Text] [Related]
56. [Therapeutic angiogenesis for diabetes mellitus related ischemic disease].
Taniyama Y; Sanada F; Morishita R
Nihon Rinsho; 2010 May; 68(5):949-52. PubMed ID: 20446597
[TBL] [Abstract][Full Text] [Related]
57. Delivery of hepatocyte growth factor mRNA from nanofibrillar scaffolds in a pig model of peripheral arterial disease.
Zaitseva TS; Yang G; Dionyssiou D; Zamani M; Sawamura S; Yakubov E; Ferguson J; Hallett RL; Fleischmann D; Paukshto MV; Huang NF
Regen Med; 2020 Jun; 15(6):1761-1773. PubMed ID: 32772903
[No Abstract] [Full Text] [Related]
58. Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease.
Penny WF; Hammond HK
Curr Gene Ther; 2004 Jun; 4(2):225-30. PubMed ID: 15180588
[TBL] [Abstract][Full Text] [Related]
59. Human studies of angiogenic gene therapy.
Gupta R; Tongers J; Losordo DW
Circ Res; 2009 Oct; 105(8):724-36. PubMed ID: 19815827
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
